tiprankstipranks
Trending News
More News >

Insmed price target lowered to $109 from $110 at UBS

UBS analyst Trung Huynh lowered the firm’s price target on Insmed (INSM) to $109 from $110 and keeps a Buy rating on the shares. Insmed’s print was straightforward, with building anticipation into a catalyst-rich period, the analyst tells investors in a research note.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue